Oxacillin Injectable Recalled for Failure to Assure Sterility
Sagent Pharmaceuticals is recalling Oxacillin for Injection (1 gram vials, Lot OXG301) due to lack of assured sterility. Approximately 65,710 vials distributed nationwide are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable pharmaceutical with lack of assured sterility. While the hazard poses a risk of serious infection to patients, no illnesses or injuries have been reported, placing it at Score 3 per the rubric for risk-of-harm products without reported actual harm.
Plain-English summary
Sagent Pharmaceuticals is recalling Oxacillin for Injection, USP, 1 gram per vial. The recall includes both 1 gram and 2 gram strength vials administered intravenously or intramuscularly as a prescription antibiotic.
The recall is due to lack of assurance of sterility. The affected lot is OXG301 with an expiration date of December 31, 2025.
Approximately 65,710 vials have been distributed nationwide across the United States. Patients and healthcare providers should not use the affected medication and should consult with their pharmacy or healthcare provider regarding alternative treatment options.
The recalled product
- Product
- Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India. NDC 25021-146-10.
- Manufacturer
- Sagent Pharmaceuticals
- Category
- Drug — Pharmaceutical Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: OXG301
- Exp 12/31/2025
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Sagent Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Sagent Pharmaceuticals
See all →- LowBusulfan Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-05-27
- CriticalDocetaxel Injection Recalled Nationwide for Stopper Particulate Matter
FDA (Drugs) · 2024-06-19
- SevereDocetaxel Injection Recalled Due to Particulate Matter in Stopper
FDA (Drugs) · 2024-06-19
- HighPrescription Corticosteroid Injectable Recalled for Particulate Matter
FDA (Drugs) · 2024-05-22
- HighOxacillin for Injection Recalled Nationwide for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-02
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15